Bladder Irritable

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Bladder Irritable trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05754190

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

This study relies on the use of a smartphone application (SOMA) that the investigators developed for tracking daily mood, pain, and activity status in acute pai…

United States800 participantsStarted 2023-06-20

Treatment: SOMA pain manager smartphone application

All recent trials (20 shown)

CompletedPhase 2

NCT03844412

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Vestibulodynia (VBD) is a complex chronic vulvar pain condition that impairs the psychological, physical, and sexual health of 1 in 6 reproductive aged women in…

United States209 participantsStarted 2019-11-04

Treatment: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream, Nortriptyline

CompletedNot Applicable

NCT03681678

Laser Therapy for Treatment of Urogenital Symptoms in Women

This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.

United States100 participantsStarted 2018-10-08

Treatment: fCO2 Laser Therapy Group

Bladder Irritable

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

All recent trials (20 shown)

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Laser Therapy for Treatment of Urogenital Symptoms in Women

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

All recent trials (20 shown)

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Laser Therapy for Treatment of Urogenital Symptoms in Women

Effectiveness of Modern Physical Agents in the Treatment of Pelvic Floor Dysfunctions

Combined Dexmedetomidine and Glycopyrrolate Therapy

Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

Trigonal vs Non Trigonal Botox Injection in OAB.

MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Efficacy of Gralise® for Chronic Pelvic Pain

Observational Study of Control Participants for the MAPP Research Network

Botulin-A Toxin Instillations and Overactive Bladder

Web-Based Survey of Pain, Stress and Complementary and Alternative Medicine

Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome

Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity

Onabotulinumtoxina Intradetrusorial Injections and NGF Expression

Female Chronic Pelvic Pain

Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity